| 1 |
35091086 | Regioselective synthesis, physicochemical properties and anticancer activity of 2-aminomethylated estrone derivatives. | 2022 May |
2 |
| 2 |
28810190 | Design, synthesis and biological evaluation of novel 2-methoxyestradiol analogs as dual selective estrogen receptor modulators (SERMs) and antiangiogenic agents. | 2017 Oct 20 |
1 |
| 3 |
21920623 | ERĪ± phenotype, estrogen level, and benzo[a]pyrene exposure modulate tumor growth and metabolism of lung adenocarcinoma cells. | 2012 Mar |
2 |
| 4 |
22077725 | Effects of estrogen metabolite 2-methoxyestradiol on tumor suppressor protein p53 and proliferation of breast cancer cells. | 2011 Dec |
2 |
| 5 |
20534756 | Resveratrol, a red wine constituent, blocks the antimitogenic effects of estradiol on human female coronary artery smooth muscle cells. | 2010 Sep |
1 |
| 6 |
19318326 | [Endocrine factors influencing melanoma progression]. | 2009 Mar |
1 |
| 7 |
17415781 | 2-methoxyestradiol induces apoptosis and cell cycle arrest in human chondrosarcoma cells. | 2007 Aug |
2 |
| 8 |
15120420 | Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. | 2004 Mar |
3 |
| 9 |
15126566 | Differential regulation of estrogen receptor subtypes alpha and beta in human aortic smooth muscle cells by oligonucleotides and estradiol. | 2004 May |
1 |
| 10 |
15386380 | In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma. | 2004 Dec 10 |
1 |
| 11 |
14670179 | 2-Methoxyestradiol exhibits a biphasic effect on VEGF-A in tumor cells and upregulation is mediated through ER-alpha: a possible signaling pathway associated with the impact of 2-ME2 on proliferative cells. | 2003 Sep-Oct |
1 |
| 12 |
11856647 | 2-methoxyestradiol induces interferon gene expression and apoptosis in osteosarcoma cells. | 2002 Feb |
1 |
| 13 |
11961123 | 2-Methoxyestradiol and analogs as novel antiproliferative agents: analysis of three-dimensional quantitative structure-activity relationships for DNA synthesis inhibition and estrogen receptor binding. | 2002 May |
2 |